Cite

HARVARD Citation

    Jardine, M. et al. (2022). Angiotensin receptor blockers for the treatment of covid-19: pragmatic, adaptive, multicentre, phase 3, randomised controlled trial. BMJ. p. . [Online]. 
  
Back to record